Immunotherapy drug opens a new era of precision medicine for cancer
Saturday, May 27, 2017 - 00:21
in Health & Medicine
With little fanfare, the Food and Drug Administration did something this week that it's never done before: The agency approved a single prescription drug, pembrolizumab (marketed by Merck as Keytruda) for treatment of solid tumors in any organ so long as the malignancy bears a specific genetic...